HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrzej J Jakubowiak Selected Research
Andrzej J Jakubowiak Research Topics
Disease
45
Multiple Myeloma
10/2022 - 10/2008
6
Neoplasms (Cancer)
01/2020 - 12/2007
4
Peripheral Nervous System Diseases (PNS Diseases)
08/2014 - 07/2010
3
Disease Progression
01/2020 - 04/2011
3
Thrombocytopenia (Thrombopenia)
01/2016 - 10/2008
2
Residual Neoplasm
01/2022 - 01/2021
2
Fatigue
08/2014 - 08/2010
2
Neutropenia
08/2014 - 10/2008
1
Plasma Cell Neoplasms
04/2022
1
Febrile Neutropenia
01/2016
1
Lymphoma (Lymphomas)
01/2016
1
Muscle Cramp (Cramp)
01/2016
1
Mitochondrial Diseases (Mitochondrial Disease)
07/2015
1
Acute-Phase Reaction
07/2015
1
Exanthema (Rash)
08/2014
1
Nausea
08/2014
1
Chest Pain (Chest Pains)
06/2012
1
Gastroenteritis
06/2012
1
Septic Shock (Toxic Shock Syndrome)
03/2011
1
Infections
03/2011
1
Human Influenza (Influenza)
03/2011
1
Cardiac Arrhythmias (Arrythmia)
03/2011
1
Pulmonary Embolism
10/2008
1
Venous Thrombosis (Deep-Vein Thrombosis)
10/2008
1
Hemorrhage
10/2008
Drug/Important Bio-Agent (IBA)
19
carfilzomib
IBA
10/2022 - 06/2012
18
Dexamethasone (Maxidex)
FDA Link
Generic
10/2022 - 10/2008
15
Lenalidomide (CC 5013)
FDA Link
10/2022 - 08/2010
15
Bortezomib (Velcade)
FDA Link
12/2017 - 10/2008
9
Proteasome Inhibitors
IBA
01/2019 - 12/2007
4
Thalidomide (Thalomid)
FDA Link
08/2014 - 07/2009
3
Pharmaceutical Preparations
IBA
01/2022 - 08/2014
3
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2019 - 12/2007
2
selinexor
IBA
01/2019 - 01/2016
2
Proteins (Proteins, Gene)
FDA Link
11/2016 - 12/2007
2
marizomib
IBA
01/2016 - 08/2014
2
elotuzumab
IBA
12/2015 - 06/2012
2
Immunomodulating Agents
IBA
07/2015 - 02/2013
2
Monoclonal Antibodies
IBA
06/2012 - 09/2011
2
liposomal doxorubicin (Doxil)
FDA Link
07/2011 - 10/2009
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
daratumumab
IBA
01/2022
1
Drug Combinations
IBA
01/2022
1
Membrane Glycoproteins (Membrane Glycoprotein)
IBA
01/2020
1
Immunoconjugates (Immunoconjugate)
IBA
01/2020
1
Epitopes
IBA
01/2020
1
Phosphotransferases (Kinase)
IBA
01/2020
1
PDZ-binding kinase
IBA
01/2020
1
OTS964
IBA
01/2020
1
Protein Kinases (Protein Kinase)
IBA
01/2020
1
ONX 0912
IBA
01/2019
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2019
1
Panobinostat
IBA
01/2019
1
Kinesins
IBA
11/2016
1
filanesib
IBA
11/2016
1
pevonedistat
IBA
01/2016
1
Transaminases (Aminotransferases)
IBA
01/2016
1
Enzyme Inhibitors (Inhibitors, Enzyme)
IBA
01/2016
1
Enzymes
IBA
01/2016
1
DNA (Deoxyribonucleic Acid)
IBA
07/2015
1
ixazomib
IBA
08/2014
1
perifosine
IBA
08/2012
1
Proto-Oncogene Proteins B-raf
IBA
03/2011
1
Steroids
IBA
03/2011
1
MTOR Inhibitors
IBA
03/2011
1
temsirolimus
FDA Link
03/2011
1
Amyloid (Amyloid Fibrils)
IBA
03/2011
1
1-dodecylpyridoxal (PLD)
IBA
10/2009
1
Melphalan (Alkeran)
FDA Link
Generic
07/2009
1
Prednisone (Sone)
FDA Link
Generic
07/2009
1
Erythropoietin
FDA Link
10/2008
1
Messenger RNA (mRNA)
IBA
12/2007
Therapy/Procedure
15
Therapeutics
04/2022 - 07/2009
2
Precision Medicine
01/2022 - 07/2015
2
Stem Cell Transplantation
01/2021 - 11/2020
1
Drug Therapy (Chemotherapy)
01/2020
1
Aftercare (After-Treatment)
11/2016
1
Autologous Transplantation
07/2009